Is a complete BVMF/AMGN34 research report available?

No complete published report is available for bvmf/AMGN34 (BVMF/AMGN34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bvmf/AMGN34 stock profile: metrics, valuation and analysis

Market cap	1.2T
Revenue (ttm)	197.4B
Net income (ttm)	45.3B
EPS (ttm)	R$83.4
P/E (trailing)	26.7x
P/E (forward)	18.5x
Dividend	R$1.25 (1.56%)
Volume	1,239
Beta	0.41

All BVMF/AMGN34 indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

USD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	31,500
Employees Change	1,300%
Employees Change Percent	4.87
Enterprise value	BRL 1.4T
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-09-07
Market cap	BRL 1.2T
Price	BRL 80.23
Price currency	BRL
Rev Per Employee	6,265,478.6x
Sector	Healthcare
Sector PE	44.89
Sector PE Fwd	12.18
Sic	2836
Symbol	bvmf/AMGN34
Website	https://www.amgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.74%
EV Earnings	31.64x
EV/EBIT	21.98x
EV/EBITDA	15.96x
EV/FCF	27.19x
EV/Sales	7.34x
FCF yield	4.35%
Forward P/E	18.52x
P/B ratio	20x
P/E ratio	26.74x
P/S ratio	6.14x
PE Ratio10 Y	25.24x
PE Ratio3 Y	29.44x
PE Ratio5 Y	25.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	33.4%
EBITDA Margin	45.33%
FCF margin	26.99%
Gross margin	71.89%
Gross Profit	BRL 141.9B
Gross Profit Growth	13.09%
Gross Profit Growth Q	12.23%
Gross Profit Growth3 Y	11.58%
Gross Profit Growth5 Y	7.36%
Net Income	BRL 45.3B
Net Income Growth	32.09%
Net Income Growth Q	65.85%
Net Income Growth Qo Q	30.57%
Net Income Growth3 Y	3.09%
Net Income Growth5 Y	8.76%
Pretax Margin	27%
Profit Margin	22.95%
Profit Per Employee	BRL 1.4M
ROA	8.67
Roa5y	8.22
ROCE	18.14
ROE	91.47
Roe5y	101.8
ROIC	19.76
Roic5y	20.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.38%
Cagr1y	48.43%
Cagr3y	23.1%
Cagr5y	16.25%
Div CAGR10	14.81%
Div CAGR3	6.97%
Div CAGR5	7.17%
EPS Growth	31.6
EPS Growth Q	64.91
EPS Growth Qo Q	30.84
EPS Growth3 Y	2.72
EPS Growth5 Y	10.3
FCF Growth	-4.06%
FCF Growth Q	82.58%
FCF Growth Qo Q	136.22%
FCF Growth3 Y	1.66%
FCF Growth5 Y	2.72%
OCF Growth	3.87%
OCF Growth Q	75.53%
OCF Growth Qo Q	82.82%
OCF Growth10 Y	2.7%
OCF Growth3 Y	4.93%
OCF Growth5 Y	5.48%
Revenue Growth	9.1x
Revenue Growth Q	9.53x
Revenue Growth Qo Q	16.66x
Revenue Growth3 Y	12.74x
Revenue Growth5 Y	8.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.42
Assets	BRL 495.5B
Cash	BRL 72.5B
Current Assets	BRL 179.2B
Current Liabilities	BRL 130.7B
Debt	BRL 296.9B
Debt EBITDA	BRL 3.27
Debt Equity	BRL 4.9
Debt FCF	BRL 5.63
Equity	BRL 60.6B
Interest Coverage	4.14
Liabilities	BRL 434.9B
Long Term Assets	BRL 316.3B
Long Term Liabilities	BRL 304.2B
Net Cash	BRL -224.4B
Net Cash By Market Cap	BRL -18.53
Net Debt EBITDA	BRL 2.51
Net Debt Equity	BRL 3.71
Net Debt FCF	BRL 4.26
Tangible Book Value	BRL -142.3B
Tangible Book Value Per Share	BRL -263
WACC	6.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.37
Inventory Turnover	1.67
Net Working Capital	BRL 4.7B
Quick ratio	0.95
Working Capital	BRL 49B
Working Capital Turnover	BRL 25.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.46%
Dividend Growth	-2.89%
Dividend Growth Years	12%
Dividend per share	BRL 1.25
Dividend Years	15
Dividend Yield	1.56%
Ex Div Date	2026-08-20
Last Dividend	BRL 0.31
Payout Frequency	Quarterly
Payout Ratio	60.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	396.44%
1Y total return	48.39%
200-day SMA	65.33
3Y total return	86.56%
50-day SMA	71.59
50-day SMA vs 200-day SMA	50over200
5Y total return	112.27%
All Time High	83.38
All Time High Change	-3.78%
All Time High Date	2026-08-19
All Time Low	5.84
All Time Low Change	1,273.8%
All Time Low Date	2013-02-19
ATR	1.53
Beta	0.41
Ch YTD	21.63
High	80.23
High52	83.38
High52 Date	2026-08-19
High52ch	-3.78%
Low	80.11
Low52	48.4
Low52 Date	2026-01-02
Low52ch	65.76%
Ma50ch	12.07%
Price vs 200-day SMA	22.8%
RSI	66.71
RSI Monthly	66.37
RSI Weekly	68.92
Sharpe ratio	0.83x
Sharpe Ratio3y	0.56x
Sharpe Ratio5y	0.47x
Sortino ratio	1.39
Sortino Ratio3y	0.98
Sortino Ratio5y	0.86
Total Return	1.1%
Tr YTD	23.26
Tr1m	16.94%
Tr1w	-0.2%
Tr3m	31.7%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	539,159,427%
Net Borrowing	6,751,337,100
Shares Insiders	0.17%
Shares Institutions	83.81%
Shares Qo Q	0%
Shares Yo Y	0.46%
Short Ratio	4.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 50.2B
Adjusted OCF	62,097,068,800
Average Volume	176.35x
Bv Per Share	112
CAPEX	BRL -11.9B
Ch10y	307.2
Ch1m	16.5
Ch1w	-0.2
Ch1y	45.74
Ch3m	31.2
Ch3y	75.71
Ch5y	91.39
Ch6m	12.67
Change	0.87%
Change From Open	0.15
Close	79.54
Days Gap	0.72
Depreciation Amortization	23,288,780,900
Dollar Volume	99,405
Earnings Date	2026-11-05
EBIT	BRL 65.9B
EBITDA	BRL 89.5B
EPS	BRL 83.38
F Score	8
FCF	BRL 52.7B
FCF EV Yield	3.68x
Financing CF	-21,370,800,000
Fiscal Year End	December
Founded	1,980
Goodwill	95,697,768,400
Graham Number	16.45557
Graham Upside	-79.49
Income Tax	BRL 8B
Investing CF	-12,392,473,600
Is Primary Listing	0
Last Earnings Date	2026-08-04
Last Report Date	2026-06-30
Last Split Date	2020-10-29
Last Split Type	Forward
Lynch Fair Value	BRL 26.28
Lynch Upside	-67.25
Ma150	66.72
Ma150ch	20.26%
Ma20	78.28
Ma20ch	2.49%
Net CF	30,882,748,800
Next Earnings Date	2026-11-05
Open	80.11
P FCF Ratio	22.98
P FCF Ratio SBC	24.14
P OCF Ratio	18.74
P OCF Ratio SBC	19.5
Payment Date	2026-09-17
Position In Range	100
Ppne	43,814,486,100
Price Date	2026-09-04
Price EBITDA	BRL 13.54
Relative Volume	7.03x
Revenue	197,362,576,000x
SBC By Revenue	1.29x
Share Based Comp	2,548,953,600
Tax By Revenue	4.05x
Tax Rate	15.01%
Tr6m	13.71%
Volume	1,239
Z Score	1.89

BVMF/AMGN34 (BVMF/AMGN34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/AMGN34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/AMGN34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BVMF/AMGN34

Frequently asked questions